Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exosome Detection for Predicting Treatment Efficacy in Advanced NSCLC With Malignant Pleural Effusion

NCT07262671 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07262671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exosome Detection for Predicting Treatment Efficacy in Advanced NSCLC With Malignant Pleural Effusion
Lead sponsor
Fudan University
Phase
Observational
Overall status
Active, not recruiting
Start date
October 16, 2025
Completion date
October 16, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc (advanced non-small cell lung cancer)